Emerging Drivers to Reshape the Kidney Fibrosis Treatment Market: Rising Prevalence Of Chronic Kidney Disease Driving Growth In The Market Due To Increasing Rates Of Diabetes And Hypertension as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Kidney Fibrosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for kidney fibrosis treatment has noticeably expanded over recent years. The market value is predicted to surge from $5.62 billion in 2024 to roughly $6.06 billion in 2025, with an impressive compound annual growth rate (CAGR) of 7.8%. factors contributing to this significant growth during the historical period include an upsurge in research and development investments directed towards fibrosis-targeting treatments, increased government support for initiatives designed to manage kidney diseases, a notable rise in patient knowledge regarding kidney transplantation as well as fibrosis treatment alternatives, advancement in healthcare infrastructure, and increased occurrence of ageing populations.

Kidney Fibrosis Treatment Market Size Forecast: What's the Projected Valuation by 2029?
The market for kidney fibrosis treatment is anticipated to witness robust expansion in the upcoming years, potentially reaching $8.21 billion by 2029 with a compound annual rate (CAGR) of 7.9%. Factors contributing to this predicted growth include the rising number of chronic kidney disease cases, greater demand for sophisticated renal fibrosis therapies, heightened awareness and early detection of kidney fibrosis, as well as the increasing use of personalized medicine in the treatment of kidney disease, and a surge in diabetes and hypertension instances. During the forecast period, key trends such as advancements in early detection and diagnostic tools, gene therapy advancements, technology incorporation into telemedicine and remote monitoring, progress in stem cell therapy, and enhanced drug delivery systems are likely to shape the industry.

View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-fibrosis-treatment-global-market-report

What Are the Drivers Transforming the Kidney Fibrosis Treatment Market?
The escalating incidence of chronic kidney ailments is anticipated to fuel the expansion of the kidney fibrosis treatment market in the future. Chronic kidney disease (CKD) represents a steady decline of kidney function over time, commonly due to factors like diabetes or hypertension, which lead to a buildup of waste substances in the body. The escalating incidence of CKD is predominantly influenced by the growing rates of diabetes which damage kidney blood vessels and hinder their filtering capacity. Kidney fibrosis treatment aids CKD patients by focusing on the scarring of kidney tissue, diminishing inflammation, and decelerating the advancement of kidney damage, eventually conserving kidney function. For example, the Centers for Disease Control and Prevention (CDC), a public health agency based in the US, estimated in May 2024 that about 14% of US adults, approximately 35.5 million individuals, are thought to be living with chronic kidney diseases. Hence, the escalating incidence of chronic kidney diseases is stimulating the growth of the kidney fibrosis treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24271&type=smp

Which Segments in the Kidney Fibrosis Treatment Market Offer the Most Profit Potential?
The kidney fibrosis treatment market covered in this report is segmented -

1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types
2) By Diagnosis: Blood Tests, Urine Tests, Imaging Tests, Kidney Biopsy
3) By Application: Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications
4) By End-User: Clinics, Research Center, Hospitals

Subsegments:
1) By Angiotensin-Converting Enzyme (Ace) Inhibitors: Enalapril, Captopri, Lisinopril, Ramipril
2) By Angiotensin Ii Receptor Blockers (Arbs): Losartan, Telmisartan, Valsartan, Irbesartan
3) By Pirfenidone: Branded Pirfenidone, Generic Pirfenidone
4) By Renin Inhibitors: Aliskiren, Experimental Renin Inhibitors
5) By Vasopeptidase Inhibitors: Omapatrilat, Sampatrilat
6) By Other Treatment Types: Anti-Inflammatory Agents, Stem Cell Therapy, Antifibrotic Agents Under Clinical Trials, Gene Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24271&type=smp

Which Firms Dominate the Kidney Fibrosis Treatment Market by Market Share and Revenue in 2025?
Major companies operating in the kidney fibrosis treatment market are F. Hoffman-La Roche Ltd., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Cara Therapeutics Inc., Gilead Sciences Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Vertex Pharmaceuticals Incorporated, Chinook Therapeutics Inc., Reata Pharmaceuticals Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Insilico Medicine Inc., Tvardi Therapeutics Inc., ProKidney LLC, Alentis Therapeutics AG, La Jolla Pharmaceutical Company, Galecto Biotech AB, Purespring Therapeutics Inc.

Which Regions Offer the Highest Growth Potential in the Kidney Fibrosis Treatment Market?
North America was the largest region in the kidney fibrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney fibrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24271

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.